Related Experiment Videos

Insights

Cutaneous fungal infections in transplant patients can appear non-specific. Early diagnosis and a combination of surgery, antifungals, and reduced immunosuppression lead to successful outcomes.

Area of Science:

  • Mycology
  • Transplant Surgery
  • Dermatology

Background:

  • Solid-organ transplant recipients are susceptible to opportunistic infections.
  • Cutaneous fungal infections in this population often present with nonspecific symptoms.
  • A high index of suspicion is crucial for timely diagnosis.

Observation:

  • Four transplant recipients (cardiac, renal, renal-pancreatic) developed primary cutaneous fungal infections.
  • Lesions manifested as papules, plaques, ulcers, and subcutaneous nodules.
  • Infections were confined to the skin, with no evidence of systemic spread.

Findings:

  • Pathogens identified included Scedosporium apiospermum, Alternaria, Aspergillus fumigatus, and dark molds (Coniothyrium-Microsphaeropsis complex).
  • Treatment involved surgical debridement, antifungal medications, and decreased immunosuppressive therapy.
  • All patients and their transplanted organs survived the infections.

Implications:

  • Prompt diagnosis and aggressive management are key for treating cutaneous fungal infections in transplant patients.
  • Multimodal therapy including surgery, antifungals, and immunosuppression adjustment improves patient and graft survival.
  • Close post-treatment follow-up is essential for optimizing cure rates.

Related Concept Videos